New England Biolabs (United States)
New England Biolabs produces and supplies recombinant and native enzyme reagents for the life science research, as well as providing products and services supporting genome editing, synthetic biology and next-generation sequencing. Derived from Wikipedia licensed CC-BY-SA.
Open Access statistics for New England Biolabs (United States), United States, covering academic research published from 2000 to 2023. Read More.
Open Access Percentage
75%
Total
Publications
1.6K
Total Open
Publications
1.2K
Total
Citations
77K
Open Access
Percentage
75%
Total
Publications
1.6K
Total Open
Publications
1.2K
Total
Citations
77K
Breakdown
Publisher Open
9%
Both
47%
Other Platform Open
19%
Closed
25%
Percentage of Open Access over time
Publisher Open
Both
Other Platform Open
Closed
Volume of Open Access over time
Open
Closed
Publisher Open
OA Journal 52%
470
Hybrid 29%
261
No Guarantees 19%
178
Other Platform Open
Domain 88%
956
Institution 21%
231
Public 17%
185
Preprint 13%
142
Other Internet 10%
112
Other Platform Locations
Name | Platform Type | Publications |
|---|---|---|
PubMed Central | Domain | 951 |
Europe PMC | Domain | 786 |
Semantic Scholar | Public | 170 |
bioRxiv | Preprint | 116 |
DOI | Other Internet | 53 |
Harvard University - Digital Access to Scholarship at Harvard (DASH) | Institution | 47 |
Research Square | Preprint | 29 |
U.S. Department of Energy Office of Scientific and Technical Information - OSTI OAI | Institution | 26 |
Figshare | Public | 25 |
University of Edinburgh - Edinburgh Research Explorer | Institution | 18 |